S. Korea: Situation must improve for aid to resume

July 20, 2006 05:22


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


South Korea's top official on dealings with North Korea said Thursday that aid to the communist country suspended after its recent missile launches wouldn't be resumed unless the current tense situation on the peninsula improves. Unification Minister Lee Jong-seok also said it was "very regrettable" that the North has suspended family reunions of relatives split by the heavily fortified Korean border. The North said Wednesday it would halt the reunions after the South refused to discuss aid at recent high-level talks, saying that Seoul was being pressured by "outsiders", an apparent allusion to UN Security Council sanctions against Pyongyang. But Lee said Thursday that "South Korea's decision to suspend aid is not to join sanctions, but it was an independent judgment as North Korea aggravated the situation by not taking into account South Korea's concerns and position."

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection